SCHEDULE: BlackRock Discloses 2.0% Stake in Outset Medical

BlackRock, Inc. has filed a Schedule 13G, reporting a beneficial ownership of 365,556 shares, representing 2.0% of the outstanding common stock of Outset Medical, Inc. as of June 30, 2026.

Summary

• BlackRock, Inc. has filed an amended Schedule 13G, indicating its beneficial ownership of Outset Medical, Inc. common stock.
• As of June 30, 2026, BlackRock beneficially owned 365,556 shares, which constitutes 2.0% of the class of securities.
• This ownership includes sole voting power and sole dispositive power over these shares.
• The filing clarifies that this reflects securities held by certain reporting business units of BlackRock, Inc. and its subsidiaries and affiliates.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it is a routine disclosure of beneficial ownership by an institutional investor and does not contain operational or financial performance data for the company.

Positives

• BlackRock, a significant institutional investor, holds a stake in Outset Medical, Inc.
• The filing confirms BlackRock's sole voting and dispositive power over its holdings, indicating clear investment intent.

Negatives

• The filing does not contain any negative financial or operational information about Outset Medical, Inc. itself, as it is a disclosure of beneficial ownership by an external entity.

Risks

• The filing does not explicitly mention any risks related to Outset Medical, Inc. or BlackRock's investment.

Future Outlook

The filing is a disclosure of beneficial ownership and does not contain forward-looking statements or guidance regarding Outset Medical, Inc.'s future performance.

Management Comments

• BlackRock, Inc. certifies that the securities were acquired and are held in the ordinary course of business and were not acquired or held for the purpose of or with the effect of changing or influencing the control of the issuer.

Industry Context

StockSavvy.ai notes that this Schedule 13G filing by BlackRock, Inc. signifies a notable institutional interest in Outset Medical, Inc., a company operating in the medical technology sector. Such filings often precede or accompany significant market activity or strategic shifts.

Comparison to Industry Standards

• As a Schedule 13G filing, this is a standard disclosure for institutional investors crossing a 5% ownership threshold or reporting changes in holdings. BlackRock's filing of 2.0% is a common level of passive institutional ownership.

Stakeholder Impact

• Shareholders: The filing indicates continued institutional interest, which can be perceived positively by the market.
• Management: The filing confirms BlackRock's passive investment approach, not seeking to influence control.

Next Steps

• BlackRock, Inc. will continue to monitor its beneficial ownership of Outset Medical, Inc. common stock.
• Further filings may be required if BlackRock's ownership stake changes significantly.

Key Dates

Keywords

Outset Medical, BlackRock, Schedule 13G, Beneficial Ownership, Institutional Investor, Common Stock, SEC Filing, Investment